iifl-logo

Novartis India Ltd Board Meeting

672.25
(-2.48%)
Oct 25, 2023|03:57:48 PM

Novartis India CORPORATE ACTIONS

02/04/2024calendar-icon
02/04/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting28 Jan 202527 Dec 2024
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 inter alia to consider and approve The intimation is filed to inform that the Board Meeting of the Company shall be held on Tuesday January 28 2025 for approval of Quarterly Financial Results for the Quarter ended as on December 31 2024. We hereby inform that the Board of Directors (Board) of the Company at its Meeting held today i.e. January 28, 2025 inter-alia have considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024 as recommended by the Audit Committee of the Company. (As Per BSE Announcement Dated on: 28/01/2025)
Board Meeting25 Oct 202427 Sep 2024
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve the Unaudited Financial Results for the quarter ended September 30 2024 Filing of the outcome of Board Meeting and Unaudited Financial Results for the quarter and half year ended September 30, 2024 (As Per BSE Announcement Dated on 25.10.2024)
Board Meeting29 Jul 202427 Jun 2024
Intimation in relation to Board meeting and closure of Trading window for period July 01, 2024 to July 31, 2024 Outcome - Unaudited Financial Results for the Quarter ended June 30, 2024 (As Per BSE Announcement dated on 29.07.2024)
Board Meeting28 Jun 202428 Jun 2024
Board Meeting outcome for meeting of Board of Directors of Novartis India Limited held on June 28, 2024 for appointment of additional Director (designated as Whole Time Director)
Board Meeting10 May 202427 Mar 2024
NOVARTIS INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve the Audited Financial Results of the Company for the year ended March 31 2024; and recommend dividend on equity shares of the Company if any for the financial year ended March 31 2024 Final Dividend & Audited Results (As per BSE Bulletin dated on 27/03/2024) Outcome of the Meeting of the Board of Directors of Novartis India Limited (the Company) held on May 10, 2024 Corporate Action - Board approved dividend Corporate Action - fixes book closure (As Per BSE Announcement dated on 10.05.2024)
Board Meeting8 May 20248 May 2024
The Resolution is passed approving the appointment of Company Secretary and Compliance officer of Novartis India Limited. The Resolution is passed approving the appointment of Company Secretary and Compliance officer of Novartis India Limited. Appointment of Company Secretary and Compliance officer in Novartis India Limited. Approval for the appointment of Company Secretary and Compliance officer by Novartis India Limited.

Novartis India: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.